189 related articles for article (PubMed ID: 7847809)
21. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
[TBL] [Abstract][Full Text] [Related]
22. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
23. [Anti-tumor effects of various interferons-alpha +5-fluorouracil via downregulation of dihydropyrimidine dehydrogenase in hepatoma cells].
Fan XY; Uchida H; Iwaki K; Kai S; Shibata K; Ohta M; Kitano S
Gan To Kagaku Ryoho; 2007 Jun; 34(6):957-9. PubMed ID: 17565266
[TBL] [Abstract][Full Text] [Related]
24. Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activity.
Shang D; Ito N; Watanabe J; Awakura Y; Nishiyama H; Kamoto T; Ogawa O
Eur Urol; 2007 Oct; 52(4):1131-9. PubMed ID: 17275163
[TBL] [Abstract][Full Text] [Related]
25. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
[TBL] [Abstract][Full Text] [Related]
26. Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors.
Lovgren TR; Tarantolo SR; Evans C; Kuszynski CA; Joshi SS
In Vivo; 2002; 16(6):541-50. PubMed ID: 12494899
[TBL] [Abstract][Full Text] [Related]
27. Combined effects of immunity and antitumor drugs against cancer. II. In vitro studies with cis-diamminedichloroplatinum in a human leukemia system.
De Filippi R; Fuggetta MP; Ricci F; Marini S; Caliendo R; Giuliani A
Chemioterapia; 1987 Dec; 6(6):410-6. PubMed ID: 2449291
[TBL] [Abstract][Full Text] [Related]
28. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line.
Zupi G; Marangolo M; Arancia G; Greco C; Laudonio N; Iosi F; Formisano G; Malorni W
Cancer Res; 1988 Nov; 48(21):6193-200. PubMed ID: 3167866
[TBL] [Abstract][Full Text] [Related]
29. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
Ishii T; Marumo K
Int J Urol; 2004 Nov; 11(11):993-1000. PubMed ID: 15509204
[TBL] [Abstract][Full Text] [Related]
30. Drug-induced modulation of carcinoembryonic antigen (CEA) expression in neoplastic cells from a patient with rectal cancer.
Cappelletti D; Cardillo A; Bonanno E; Prete SP; Cucchiara G; Turriziani M; Greiner JW; Cottarelli A; Breda E; Aquino A; Bonmassar E; De Vecchis L
J Exp Clin Cancer Res; 2000 Dec; 19(4):467-9. PubMed ID: 11277324
[TBL] [Abstract][Full Text] [Related]
31. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
[TBL] [Abstract][Full Text] [Related]
32. Effects of interferon-beta in combination with 5-fluorouracil on the growth of esophageal cancer cells in vitro.
Tsunoo H; Komura S; Ohishi N; Akiyama S; Kasai Y; Ito K; Nakao A; Yagi K
Anticancer Res; 2001; 21(5):3301-6. PubMed ID: 11848487
[TBL] [Abstract][Full Text] [Related]
33. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
34. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
Jordan A; Stein J
Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
[TBL] [Abstract][Full Text] [Related]
35. Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.
Wadler S; Wersto R; Weinberg V; Thompson D; Schwartz EL
Cancer Res; 1990 Sep; 50(18):5735-9. PubMed ID: 1697499
[TBL] [Abstract][Full Text] [Related]
36. Immuno-chemotherapy of advanced colorectal cancer with alpha-2a interferon and 5-fluorouracil. Immunopharmacological studies.
De Filippi R; Cucchiara G; Prete SP; Marini S; Ricci F; Nunziata C; Turriziani M; Bonmassar E; Fuggetta MP; De Vecchis L
Ann Oncol; 1991; 2(10):759-64. PubMed ID: 1801883
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase.
Schwartz EL; Baptiste N; O'Connor CJ; Wadler S; Otter BA
Cancer Res; 1994 Mar; 54(6):1472-8. PubMed ID: 8137250
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure.
Failli A; Consolini R; Legitimo A; Orsini G; Romanini A; Spisni R; Castagna M; Miccoli P
J Biol Regul Homeost Agents; 2011; 25(4):575-88. PubMed ID: 22217990
[TBL] [Abstract][Full Text] [Related]
39. Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
Okubo A; Sone S; Tanaka M; Ogura T
Cancer Res; 1989 Jan; 49(2):265-70. PubMed ID: 2463072
[TBL] [Abstract][Full Text] [Related]
40. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia.
Fuggetta MP; D'Onofrio C; Bonmassar E
Ann Ist Super Sanita; 1990; 26(3-4):385-95. PubMed ID: 1708953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
